PODD - Insulet - Stock Price & Dividends

Insulet Corporation is a pioneer in the development, manufacturing, and sales of innovative insulin delivery systems, catering to individuals living with insulin-dependent diabetes. The company's flagship Omnipod platform boasts a range of cutting-edge products that aim to simplify diabetes management and improve the quality of life for its users.

The Omnipod 5 Automated Insulin Delivery System is a prime example of the company's commitment to innovation. This advanced system features a proprietary AID algorithm embedded in the Pod, which seamlessly integrates with a third-party continuous glucose monitor via wireless Bluetooth communication. This integration enables the system to automatically adjust insulin doses based on real-time glucose levels, providing users with a more personalized and effective diabetes management experience.

In addition to the Omnipod 5, the company offers Omnipod DASH, a user-friendly system that features a Bluetooth-enabled Pod controlled by a smartphone-like Personal Diabetes Manager. This intuitive device boasts a color touch screen user interface, making it easy for users to navigate and manage their insulin delivery. Furthermore, the Omnipod GO is a standalone, wearable insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for up to 72 hours, offering users greater flexibility and convenience.

Insulet Corporation's products are widely available through a network of independent distributors, pharmacy channels, and direct sales in key markets including the United States, Canada, Europe, the Middle East, Australia, and other international regions. With a strong online presence, the company provides easy access to its products and resources through its website, https://www.insulet.com.

Founded in 2000 and headquartered in Acton, Massachusetts, Insulet Corporation has established itself as a leader in the diabetes management industry, dedicated to improving the lives of individuals living with insulin-dependent diabetes.